Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2022

View Archived Issues

New PET ligand allows in vivo pharmacological evaluation of agents targeting mutant HTT expression

New in vitro model represents the 3D architecture, composition and mechanics of connective tissues

DPEP1 antagonist LSALT shows promise in preclinical models of acute kidney injury

Scientists identify role of PDGF-D-PDGFR-beta signaling pathway in survival of human NK cells

Discovery of novel monoclonal antibodies against emerging SARS-CoV-2 variants of concern

Non-muscle-targeted AAV8/DC190-ASM gene therapy for treating limb girdle muscular dystrophy 2B

IFM Due patents hSTING antagonists for cancer

Nanjing Zhengxiang Pharmaceuticals divulges DHODH inhibitors

Korean researchers synthesize PDE5A and HDAC6 dual inhibitors for Alzheimer's

Caregen identifies new antivirals for SARS-CoV-2

Eisai divulges new OX2 receptor agonists for narcolepsy

MDL-001 significantly reduces SARS-CoV-2 viral load in lungs in preclinical study

Immunome's antibody cocktail effective against live versions of SARS-CoV-2 Omicron variant in vitro

Xanadu signs agreements with Yale to support development of intranasal SARS-CoV-2 vaccine booster

SENS-401 shows good local bioavailability in sensorineural hearing loss model

For pain signaling, endocytosis is not the end

New drug combinations with synergistic inhibitory activity against SARS-CoV-2

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...